Mohs micrographic surgery with MART-1 immunostaining has durable low local recurrence rates for in situ and invasive melanomas

J Am Acad Dermatol. 2021 Jan;84(1):196-198. doi: 10.1016/j.jaad.2020.04.086. Epub 2020 Apr 25.

Authors

Affiliations

¹ Division of Dermatologic Surgery, University of Pennsylvania, Philadelphia. Electronic address: [email protected].
² Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia.
³ George Washington University School of Medicine, Washington, DC.
⁴ Perelman School of Medicine, University of Pennsylvania, Philadelphia.
⁵ Division of Dermatologic Surgery, University of Pennsylvania, Philadelphia.

PMID: 32339704
DOI: 10.1016/j.jaad.2020.04.086

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Female
Humans
Immunohistochemistry
MART-1 Antigen / analysis*
Male
Margins of Excision
Melanoma / chemistry
Melanoma / pathology
Melanoma / surgery*
Middle Aged
Mohs Surgery
Neoplasm Invasiveness
Neoplasm Recurrence, Local* / pathology
Neoplasm, Residual / chemistry
Retrospective Studies
Skin Neoplasms / chemistry
Skin Neoplasms / pathology
Skin Neoplasms / surgery*
Young Adult

Substances

MART-1 Antigen